A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
Public ClinicalTrials.gov record NCT01170078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study Comparing the Pharmacokinetics of Epoetin Hospira and Epoetin Alfa (Amgen) When Administered Intravenously in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assessed the comparability of the pharmacokinetics (PK) of epoetin following intravenous administration of Hospira Epoetin and Epogen/Epoetin Alfa (Amgen) in patients with chronic renal failure receiving hemodialysis treatment.
Study identification
- NCT ID
- NCT01170078
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2010 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Mar 20, 2017
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Downey | California | 90241 | — |
| Not listed | Tarzana | California | 91356-6123 | — |
| Not listed | Denver | Colorado | 80230 | — |
| Not listed | Middlebury | Connecticut | 06762 | — |
| Not listed | Lauderdale Lakes | Florida | 33313 | — |
| Not listed | Miami | Florida | 33150 | — |
| Not listed | Miami | Florida | 33173 | — |
| Not listed | Gurnee | Illinois | 60031 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | Pontiac | Michigan | 48341 | — |
| Not listed | Minneapolis | Minnesota | 55404 | — |
| Not listed | Gulfport | Mississippi | 39501 | — |
| Not listed | Philadelphia | Pennsylvania | 19106 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Knoxville | Tennessee | 37923 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Houston | Texas | 77099 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Alexandria | Virginia | 22306 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01170078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2017 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01170078 live on ClinicalTrials.gov.